A Proposal for Creating a Guideline for Cancer Registration of the Fibromatosis, PEComa Group, Malignant Lymphoma In Situ and Dendritic Cell Tumors (III)
유창영, 강창석, 최윤라, 강혜연, 김진만, Koh Young-Hye, 이주희, 이승숙, 김인선, 김동훈, 박용구, 손진희,
소속 상세정보
유창영 ( Yoo Chang-Young )
Catholic University St. Vincent’s Hospital Department of Pathology
강창석 ( Kang Chang-Suk )
Catholic University School of Medicine Yeouido St. Mary’s Hospital Department of Pathology
최윤라 ( Choi Yoon-La )
Sungkyunkwan University School of Medicine Samsung Medical Center Department of Pathology
강혜연 ( Kang Hye-Yoon )
CHA University Bundang CHA Hospital Department of Pathology
김진만 ( Kim Jin-Man )
Chungnam National University College of Medicine Department of Pathology
( Koh Young-Hye )
Sungkyunkwan University School of Medicine Samsung Medical Center Department of Pathology
이주희 ( Lee Joo-Hee )
Kyung Hee University School of Medicine Department of Pathology
이승숙 ( Lee Seung-Sook )
Korea Cancer Center Hospital Department of Pathology
김인선 ( Kim In-Sun )
Korea University College of Medicine Department of Pathology
김동훈 ( Kim Dong-Hoon )
Sungkyunkwan University School of Medicine Department of Pathology
박용구 ( Park Yong-Ku )
Kyung Hee University School of Medicine Department of Pathology
손진희 ( Sohn Jin-Hee )
Sungkyunkwan University School of Medicine Department of Pathology
KMID : 0357920120460050436
Abstract
Background : Understanding the biologic behavior of a tumor is a prerequisite for tumor registration code assignment. The aim of this report was to propose appropriate behavior codes of the International Classification of Disease Oncology 3 (ICD-O3) to rare, yet pathologically interesting hematopoietic and soft tissue tumors.
Methods : The Study Group for Hematopathology, the Bone and Soft Tissue Pathology Study Group, and the Cancer Registration Committee prepared the questionnaire containing provisional behavior codes of selected diseases.
Results : In situ lesions of mantle cell and follicular lymphomas, dendritic cell tumors, and neoplasms with perivascular epithelioid cell differentiation (PEComa), not otherwise specified were classified as malignant (-/3). The fibromatosis group, with the exception of lipofibromatosis, was proposed as benign (-/0). Lipofibromatosis and several diseases that belong to the PEComa group were proposed as uncertain malignant potential (-/1). For the hematologic and soft tissue tumors, 274 and 288 members of the Korean Society of Pathologists, respectively, provided opinions through questionnaire, and most responders showed agreement with the provisional behavior code proposed.
Conclusions : The determination of behavior codes for the rare diseases described in this study, especially those of the PEComa group or malignant lymphoma, could be viewed as impractical and premature, but this study provides the basis for future research on this topic.
키워드
ICD-O3; Behavior code; Hematologic malignancy; Soft tissue neoplasms
원문 및 링크아웃 정보
등재저널 정보